Werner Lanthaler
Director/Board Member presso AC IMMUNE SA
Patrimonio netto: 24 M $ in data 31/03/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Andrea Pfeifer | M | 66 | 21 anni | |
Mario Polywka | M | 61 | 20 anni | |
Douglas Williams | M | 66 | 6 anni | |
Craig Johnstone | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | 12 anni |
Iris Löw-Friedrich | M | 63 | 10 anni | |
Anthony Adam Rosenberg | M | 71 | 7 anni | |
Monika Bütler | M | 63 | 3 anni | |
Oliver Sol | M | 58 | 8 anni | |
Monica Shaw | M | 46 | 3 anni | |
Ana Cespedes | M | 51 | 2 anni | |
Christopher Roberts | M | 35 | 5 anni | |
Roy Ervin Twyman | M | 68 | 5 anni | |
Beth Delgiacco | F | - | 6 anni | |
Camilla Sylvest | F | 52 | 2 anni | |
Piergiorgio Donati | M | 54 | 6 anni | |
Steve Krognes | M | 56 | 1 anni | |
James Daly | M | 63 | 6 anni | |
Jean-Fabien Monin | M | 54 | 15 anni | |
Carl June | M | 70 | 4 anni | |
Pamela Klein | M | 63 | 8 anni | |
Gary Waanders | M | 60 | - | |
Joseph deBethizy | M | 74 | 9 anni | |
Laetitia Rouxel | F | 51 | 1 anni | |
Matthias Evers | M | 51 | 2 anni | |
Hemamalini Moorthy | F | 54 | 2 anni | |
Constanze Ulmer-Eilfort | M | 62 | 3 anni | |
Filip Borgions | M | - | 9 anni | |
Hinnerk Rohwedder | M | - | 3 anni | |
Luc Truyen | M | 59 | 2 anni | |
Peter Ulrichts | M | 44 | 1 anni | |
Mark Danton | M | 60 | 5 anni | |
Julian Snow | M | - | - | |
Howard Donovan | M | 49 | 2 anni | |
Karl Gubitz | M | 54 | 3 anni | |
Ralph Spillner | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | - |
Bojana Portmann | M | 43 | 13 anni | |
Klaus Martin | M | - |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | 4 anni |
Marc Schorpion | M | 66 | 6 anni | |
Arjen Lemmen | M | 39 | 8 anni | |
Julien Rongère | M | 47 | 7 anni | |
Alexandre Caratsch | M | 59 | 6 anni | |
Christophe Muller | M | 53 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | - |
Camilla Languille | F | 41 | 2 anni | |
Elaine Sullivan | M | 63 | 9 anni | |
Madiha Derouazi | M | 51 | - | |
Sonia Maria Poli | M | 59 | 7 anni | |
Wolfgang Barth | M | - | - | |
Kari Kapsch | M | 60 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | 25 anni |
Cord Dohrmann | M | 60 | 14 anni | |
Roland Sackers | M | 56 | 5 anni | |
Nuno Mendonça | M | 42 | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Martin Velasco | M | 70 | 18 anni | |
Reinhard Kandera | M | 54 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 12 anni |
Thomas Lingelbach | M | 60 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 7 anni |
Timm H. Jessen | M | 62 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | 5 anni |
Eric Castaldi | M | 59 | 7 anni | |
Michel Gréco | M | 80 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 anni |
Peter Bollmann | M | 71 | 6 anni | |
David Lacey | M | 71 | 7 anni | |
Wolfgang Plischke | M | 72 | 7 anni | |
Claus Tycho Bræstrup | M | 79 | - | |
Walter Wenninger | M | 86 | 6 anni | |
Charmion Gillmore | F | - | - | |
Bernd Hirsch | M | 53 | - | |
Alan Colowick | M | 61 | - | |
Paul Herrling | M | 78 | 3 anni | |
Friedrich von Bohlen und Halbach | M | 60 | 5 anni | |
Mustapha Bakali | M | 62 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 6 anni |
James Sulat | M | 73 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 anni |
Andreas Muhs | M | 62 | 13 anni | |
Kasim Kutay | M | 59 | - | |
Michael Shalmi | M | 59 | - | |
Dirk Beeusaert | M | 59 | 5 anni | |
Andreas Pinkwart | M | 64 | 3 anni | |
Monika Conradt | F | - | - | |
Nicolas Leupin | M | 50 | 3 anni | |
Paul Sekhri | M | 66 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | - |
R. Woods | M | 57 | 5 anni | |
Wim Parys | M | 64 | 3 anni | |
Cony D’Cruz | M | 62 | 9 anni | |
Johannes Streffer | M | 56 | 2 anni | |
Marie Kosco-Vilbois | M | 67 | 5 anni | |
David Ebsworth | M | 69 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 anni |
Yvonne Greenstreet | M | 61 | 1 anni | |
Colin Bond | M | 64 | 6 anni | |
Corey Goodman | M | 72 | 2 anni | |
Michael Bart Sheffery | M | 73 | - | |
Peter John Fellner | M | 80 | 6 anni | |
Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 anni |
Harrold van Barlingen | M | 58 | 7 anni | |
Veit Sorger | M | 81 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | - |
Enno Spillner | M | 55 | 7 anni | |
Bruno Montanari | M | 49 | 7 anni | |
Mary C. Tanner | F | 73 | 9 anni | |
Jeffrey Farrow | M | 62 | 2 anni | |
Roland Oetker | M | 75 | 3 anni | |
John Paul de Koning | M | 55 | 8 anni | |
Gerd Zettlmeissl | M | 68 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 anni |
Tim Tasker | M | 70 | - | |
Leesa Gentry | F | 54 | 13 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Germania | 34 | 34.00% |
Svizzera | 28 | 28.00% |
Paesi Bassi | 26 | 26.00% |
Austria | 10 | 10.00% |
Regno Unito | 3 | 3.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Werner Lanthaler
- Contatti personali